Clinical Trial Update: A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

View source ↗

Summary

A real-world study evaluating ixazomib citrate in people with multiple myeloma has completed. The sponsor is Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Ixazomib citrate (Ixazomib)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma | Status: COMPLETED